Technical Analysis for ELOX - Eloxx Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 1.00 11.11% 0.10
ELOX closed up 9.76 percent on Wednesday, February 21, 2024, on 36 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 29
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Bullish Engulfing Bullish 11.11%
Narrow Range Bar Range Contraction 11.11%
Lower Bollinger Band Walk Weakness 11.11%
New 52 Week Low Weakness 11.11%
Wide Bands Range Expansion 11.11%
Oversold Stochastic Weakness 11.11%
New 52 Week Closing Low Bearish 21.95%
New Downtrend Bearish 21.95%
NR7 Range Contraction 21.95%
Narrow Range Bar Range Contraction 21.95%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 40 minutes ago
Up 5% 40 minutes ago
Up 3% 40 minutes ago
Up 2% 40 minutes ago
Up 1% 40 minutes ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eloxx Pharmaceuticals, Inc. Description

Eloxx Pharmaceuticals, Inc. (ELOX) is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. As a consequence, patients with premature stop codon diseases have reduced or eliminated protein production from the mutation bearing allele accounting for some of the most severe phenotypes in these genetic diseases. These premature stop codons have been identified in over 1,800 rare and ultra-rare diseases. Read-through therapeutic development is focused on extending mRNA half-life and increasing protein synthesis by enabling the cytoplasmic ribosome to read through premature stop codons to produce full-length proteins. Eloxx’s lead product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development focusing on cystic fibrosis and cystinosis. ELX-02 is an investigational drug that has not been approved by any global regulatory body. Eloxx is headquartered in Waltham, MA, with R&D operations in Rehovot, Israel.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Clinical Development Rare Diseases Molecular Biology Genetics Gene Expression Genetic Diseases Cystic Fibrosis Molecular Genetics Messenger RNA Rehovot Protein Biosynthesis Rare And Ultra Rare Diseases

Is ELOX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.9
52 Week Low 0.7705
Average Volume 46,753
200-Day Moving Average 5.09
50-Day Moving Average 4.53
20-Day Moving Average 3.66
10-Day Moving Average 2.60
Average True Range 0.50
RSI (14) 17.36
ADX 28.12
+DI 9.79
-DI 46.93
Chandelier Exit (Long, 3 ATRs) 3.99
Chandelier Exit (Short, 3 ATRs) 2.27
Upper Bollinger Bands 6.72
Lower Bollinger Band 0.59
Percent B (%b) 0.05
BandWidth 167.60
MACD Line -1.05
MACD Signal Line -0.67
MACD Histogram -0.3771
Fundamentals Value
Market Cap 2.83 Million
Num Shares 3.14 Million
EPS -8.88
Price-to-Earnings (P/E) Ratio -0.10
Price-to-Sales 0.00
Price-to-Book 6.31
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.99
Resistance 3 (R3) 0.96 0.89 0.97
Resistance 2 (R2) 0.89 0.87 0.91 0.97
Resistance 1 (R1) 0.90 0.86 0.89 0.93 0.96
Pivot Point 0.83 0.83 0.83 0.85 0.83
Support 1 (S1) 0.84 0.81 0.84 0.87 0.84
Support 2 (S2) 0.77 0.80 0.79 0.83
Support 3 (S3) 0.78 0.77 0.83
Support 4 (S4) 0.81